Annual Report And Accounts

Overview

The report describes a challenging 2023, with Group sales falling to £59.6m after the Manufacturing Pause. Clinical development nevertheless progressed: the Grass MATA MPL Phase III trial met its primary endpoint, while the VLP Peanut Phase I PROTECT trial continued after beginning participant dosing in March 2023. On sustainability, the company reports Scope 1, 2 and partial Scope 3 emissions and has committed to reducing Scope 1 and 2 by 30% and Scope 3 by 20% by 2030, followed by a 95% total-emissions reduction by 2050.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 July 2022 – 30 June 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Provider
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services